Literature DB >> 9604806

Primary hyperoxaluria type 2: enzymology.

C F Giafi1, G Rumsby.   

Abstract

Deficiency of the enzyme D-glycerate dehydrogenase (D-GDH) which also has glyoxylate reductase (GR) activity, is believed to be the underlying cause of primary hyperoxaluria type 2 (PH2). We have established the reaction kinetics of this enzyme in human liver and using these parameters have developed a microassay for the measurement of D-GDH and GR on needle liver biopsies obtained from patients with suspected primary hyperoxaluria. Tissue distribution studies of the two enzyme activities suggest that more than one enzyme with D-GDH activity is present in human tissues and the one with associated GR activity is mainly confined to the liver. The clinical significance of these findings for diagnosis and treatment is discussed.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9604806

Source DB:  PubMed          Journal:  J Nephrol        ISSN: 1121-8428            Impact factor:   3.902


  4 in total

Review 1.  Primary and secondary hyperoxaluria: Understanding the enigma.

Authors:  Bhavna Bhasin; Hatice Melda Ürekli; Mohamed G Atta
Journal:  World J Nephrol       Date:  2015-05-06

2.  Transplantation outcomes in primary hyperoxaluria.

Authors:  E J Bergstralh; C G Monico; J C Lieske; R M Herges; C B Langman; B Hoppe; D S Milliner
Journal:  Am J Transplant       Date:  2010-09-17       Impact factor: 8.086

3.  Restrictive cardiomyopathy in a patient with primary hyperoxaluria type II.

Authors:  Matthias R Schulze; Rolf Wachter; Alexander Schmeisser; Rainer Fischer; Ruth H Strasser
Journal:  Clin Res Cardiol       Date:  2006-02-17       Impact factor: 5.460

Review 4.  [Calcium oxalate stones and hyperoxaluria. What is certain? What is new?].

Authors:  M Straub; R E Hautmann; A Hesse; L Rinnab
Journal:  Urologe A       Date:  2005-11       Impact factor: 0.639

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.